Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Heparin for Unexplained Recurrent Pregnancy Loss
NCT02144064Phase 3Unknown
- Sponsor
- Benha University
- Start
- Jun 2019
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in recurrent pregnancy loss (RPL), sponsored by Benha University. Status: unknown.
02
Drugs
heparin
03
Conditions
recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT02144064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144064.